CA2633752A1 - Composes anti-viraux - Google Patents

Composes anti-viraux Download PDF

Info

Publication number
CA2633752A1
CA2633752A1 CA002633752A CA2633752A CA2633752A1 CA 2633752 A1 CA2633752 A1 CA 2633752A1 CA 002633752 A CA002633752 A CA 002633752A CA 2633752 A CA2633752 A CA 2633752A CA 2633752 A1 CA2633752 A1 CA 2633752A1
Authority
CA
Canada
Prior art keywords
group
compound
product
hydrogen
c6alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002633752A
Other languages
English (en)
Inventor
David A. Betebenner
David A. Degoey
Clarence J. Maring
Allan C. Krueger
Nobuhiko Iwasaki
Todd W. Rockway
Curt S. Cooper
David D. Anderson
Pamela L. Donner
Brian E. Green
Dale J. Kempf
Dachun Liu
Keith F. Mcdaniel
Darold L. Madigan
Christopher E. Motter
John K. Pratt
Jason P. Shanley
Michael D. Tufano
Rolf Wagner
Rong Zhang
Akhteruzzaman Molla
Hongmei Mo
Tami J. Pilot-Matias
Sherie Vl. Masse
Robert J. Carrick
Weping He
Liangjun Lu
David J. Grampovnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2006/048685 external-priority patent/WO2007081517A2/fr
Publication of CA2633752A1 publication Critical patent/CA2633752A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
CA002633752A 2005-12-21 2006-12-20 Composes anti-viraux Abandoned CA2633752A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75247305P 2005-12-21 2005-12-21
US60/752,473 2005-12-21
PCT/US2006/048685 WO2007081517A2 (fr) 2005-12-21 2006-12-20 Composes anti-viraux

Publications (1)

Publication Number Publication Date
CA2633752A1 true CA2633752A1 (fr) 2007-07-19

Family

ID=39830150

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002633752A Abandoned CA2633752A1 (fr) 2005-12-21 2006-12-20 Composes anti-viraux

Country Status (6)

Country Link
JP (1) JP2009521460A (fr)
CN (3) CN101443334A (fr)
CA (1) CA2633752A1 (fr)
ES (1) ES2348557T3 (fr)
RU (1) RU2441010C2 (fr)
ZA (2) ZA200805418B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113582842A (zh) * 2021-07-26 2021-11-02 苏州求索生物科技有限公司 一种乙醇酸苯甲酯的制备工艺

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG172352A1 (en) * 2008-12-23 2011-07-28 Abbott Lab Anti-viral compounds
SG174214A1 (en) * 2009-03-25 2011-10-28 Abbott Lab Antiviral compounds and uses thereof
RU2644351C1 (ru) * 2016-11-15 2018-02-09 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) (3S)-4-[6-(Пурин-6-иламино)гексаноил]-3,4-дигидро-3-метил-7,8-дифтор-2Н-[1,4]бензоксазин и (3R)-4-[6-(Пурин-6-иламино)гексаноил]-3,4-дигидро-3-метил-7,8-дифтор-2Н-[1,4]бензоксазин, обладающие противовирусной активностью
EP3594205A1 (fr) * 2018-07-09 2020-01-15 Abivax Dérivés phényl-n-aryl pour traiter une infection par le virus d'arn
CN111518022A (zh) * 2019-02-02 2020-08-11 华东理工大学 具有杀虫活性的芳(杂)环醚类化合物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003321472A (ja) * 2002-02-26 2003-11-11 Takeda Chem Ind Ltd Grk阻害剤
WO2004065392A1 (fr) * 2003-01-24 2004-08-05 Smithkline Beecham Corporation Pyridines et pyrimidines condensees et leur utilisation en tant que ligands du recepteur alk-5
EP1608631A4 (fr) * 2003-03-28 2008-08-20 Scios Inc Inhibiteurs bi-cycliques a base de pyrimidine de tgf beta
JP5129957B2 (ja) * 2003-07-03 2013-01-30 ミリアド ジェネティクス, インコーポレイテッド カスパーゼの活性化因子およびアポトーシスの誘発因子としての4−アリールアミノ−キナゾリン
EP1675861B1 (fr) * 2003-08-29 2015-12-23 Vernalis (R&D) Ltd. Composes pyrimidothiophene
GB0326168D0 (en) * 2003-11-10 2003-12-17 Arrow Therapeutics Ltd Chemical compounds
WO2005105761A1 (fr) * 2004-04-28 2005-11-10 Arrow Therapeutics Limited Derives de morpholinylanilinoquinazoline utilises en tant qu'agents antiviraux
KR20070083484A (ko) * 2004-07-14 2007-08-24 피티씨 테라퓨틱스, 인크. C형 간염 치료 방법
GB0416168D0 (en) * 2004-07-20 2004-08-18 Vernalis Cambridge Ltd Pyrmidothiophene compounds
AR052771A1 (es) * 2004-09-30 2007-04-04 Tibotec Pharm Ltd Pirimidinas biciclicas inhibidoras del vhc
AR054122A1 (es) * 2005-05-12 2007-06-06 Tibotec Pharm Ltd Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas
US7816351B2 (en) * 2005-09-23 2010-10-19 Equispharm Co., Ltd 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113582842A (zh) * 2021-07-26 2021-11-02 苏州求索生物科技有限公司 一种乙醇酸苯甲酯的制备工艺

Also Published As

Publication number Publication date
JP2009521460A (ja) 2009-06-04
ZA200805418B (en) 2011-12-28
CN101384592A (zh) 2009-03-11
ES2348557T3 (es) 2010-12-09
RU2441010C2 (ru) 2012-01-27
ZA201107667B (en) 2012-07-25
CN101443334A (zh) 2009-05-27
RU2008129782A (ru) 2010-01-27
CN101384591A (zh) 2009-03-11

Similar Documents

Publication Publication Date Title
EP1971611B1 (fr) Composes anti-viraux
US8236950B2 (en) Anti-viral compounds
US7763731B2 (en) Anti-viral compounds
AU2006330924B2 (en) Anti-viral compounds
RU2390522C2 (ru) Гетероциклические соединения
RU2441010C2 (ru) Противовирусные соединения
TWI392677B (zh) 抗病毒化合物、其製備方法及用途
MX2008008161A (en) Anti-viral compounds
EP2345652A1 (fr) Composées antivirales
MX2008008164A (en) Anti-viral compounds
BRPI0620440A2 (pt) compostos antivirais
CZ20004500A3 (cs) Protizánětové sloučeniny inhibující buněčnou adhesi

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20141203